Parallel Mapping for Ventricular Tachycardia

NCT04477499 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2023-01-10

No results posted yet for this study

Summary

Catheter ablation in patients with ventricular tachycardia using a new mapping algorithm called, parallel mapping, that is aimed to increase the specificity of mapping and the outcome of ablation.

Conditions

  • Ventricular Tachycardia (V-Tach)
  • Implantable Cardioverter Defibrillator (ICD)
  • Arrythmia

Sponsors & Collaborators

  • Biosense Webster, Inc.

    collaborator INDUSTRY
  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Jakub Sroubek, MD, PhD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04477499 on ClinicalTrials.gov